ATE271378T1 - Neue galenische dispergierbare und lösliche paracetamol-zubereitung, methode zu deren herstellung und deren anwendungen - Google Patents

Neue galenische dispergierbare und lösliche paracetamol-zubereitung, methode zu deren herstellung und deren anwendungen

Info

Publication number
ATE271378T1
ATE271378T1 AT01976327T AT01976327T ATE271378T1 AT E271378 T1 ATE271378 T1 AT E271378T1 AT 01976327 T AT01976327 T AT 01976327T AT 01976327 T AT01976327 T AT 01976327T AT E271378 T1 ATE271378 T1 AT E271378T1
Authority
AT
Austria
Prior art keywords
dispersible
soluble
applications
production
granulate
Prior art date
Application number
AT01976327T
Other languages
English (en)
Inventor
Mart N Luis Carvajal
Asensio Juan Carlos Asensio
Tirado Francisco Javie Sevilla
Original Assignee
Belmac S A Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Belmac S A Lab filed Critical Belmac S A Lab
Application granted granted Critical
Publication of ATE271378T1 publication Critical patent/ATE271378T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT01976327T 2000-11-03 2001-10-24 Neue galenische dispergierbare und lösliche paracetamol-zubereitung, methode zu deren herstellung und deren anwendungen ATE271378T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200002653A ES2174734B1 (es) 2000-11-03 2000-11-03 Nueva formulacion galenica de paracetamol dispersable y soluble, procedimiento para su preparacion y aplicaciones.
PCT/ES2001/000402 WO2002036101A1 (es) 2000-11-03 2001-10-24 Nueva formulacion galenica de paracetamol dispersable y soluble, procedimiento para su preparacion y aplicaciones

Publications (1)

Publication Number Publication Date
ATE271378T1 true ATE271378T1 (de) 2004-08-15

Family

ID=8495530

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01976327T ATE271378T1 (de) 2000-11-03 2001-10-24 Neue galenische dispergierbare und lösliche paracetamol-zubereitung, methode zu deren herstellung und deren anwendungen

Country Status (9)

Country Link
US (1) US6620433B2 (de)
EP (1) EP1331001B1 (de)
JP (1) JP2004512355A (de)
AT (1) ATE271378T1 (de)
DE (1) DE60104442T2 (de)
ES (1) ES2174734B1 (de)
PL (1) PL355106A1 (de)
PT (1) PT1331001E (de)
WO (1) WO2002036101A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0114069D0 (en) 2001-06-08 2001-08-01 Smithkline Beecham Plc Composition
US6581767B2 (en) * 2001-08-20 2003-06-24 Wen-Chien Cheng Golf bag base
EP1622587B1 (de) * 2003-05-02 2010-04-28 Globopharm Pharmazeutische Produktions- und Handelsgesellschaft m.b.H. Feste pharmazeutische zubereitung enthaltend levothyroxin- und/oder liothyroninsalze
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
EP3216445A1 (de) * 2004-05-28 2017-09-13 Imaginot Pty Ltd. Abgabesystem für eine orale therapeutische verbindung
EP3263117A1 (de) * 2005-11-28 2018-01-03 Imaginot Pty Ltd. Abgabesystem für eine orale therapeutische verbindung
KR101465647B1 (ko) * 2013-02-25 2014-11-27 김성호 가용성 타블렛형 청즙차의 제조방법
ES2929945T3 (es) * 2013-11-13 2022-12-05 National Defense Education And Res Foundation Nueva composición de un compuesto de acetaminofeno sin efectos secundarios sobre el hígado
EP2987482A1 (de) 2014-08-22 2016-02-24 Santa Farma Ilaç Sanayi A.S. Lösliche und dispergierbare pharmazeutische Formulierung enthaltend Deferasirox
JP6858729B2 (ja) * 2018-05-25 2021-04-14 ▲財▼▲団▼法人国防教育研究基金会Ｎａｔｉｏｎａｌ Ｄｅｆｅｎｓｅ Ｅｄｕｃａｔｉｏｎ Ａｎｄ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ 肝臓に対する副作用がない、新しいアセトアミノフェン複合組成

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2092893B1 (de) * 1970-06-29 1973-07-13 Bru Jean
US4309408A (en) * 1978-11-16 1982-01-05 Beecham Group Limited Effervescent powders
CA1209040A (fr) 1982-12-21 1986-08-05 Jean Bru Procede de fabrication de granules et comprimes effervescents
ES2060736T3 (es) * 1989-01-12 1994-12-01 Bayer Ag Composicion antiacida analgesica efervescente con un contenido en sodio reducido.
US4942039A (en) 1989-05-09 1990-07-17 Miles Inc. Effervescent analgesic antacid composition having reduced sodium content
CA2021548A1 (en) * 1989-09-01 1991-03-02 Ronald Nash Duvall Effervescent cold or sinus allergy medicine composition having reduced sodium content
GB9601398D0 (en) * 1996-01-24 1996-03-27 Piper Edwina M Composition
DE69817189T2 (de) * 1998-11-23 2004-06-17 E-Pharma Trento S.P.A., Trento Ravina Verfahren zur Herstellung eines Brausegranulats
US6544557B2 (en) * 2001-01-09 2003-04-08 Pan Pharmaceutical Limited Effervescent tablet compositions

Also Published As

Publication number Publication date
ES2174734A1 (es) 2002-11-01
US6620433B2 (en) 2003-09-16
PL355106A1 (en) 2004-04-05
PT1331001E (pt) 2004-11-30
DE60104442T2 (de) 2005-09-15
EP1331001A1 (de) 2003-07-30
DE60104442D1 (de) 2004-08-26
US20020197312A1 (en) 2002-12-26
WO2002036101A1 (es) 2002-05-10
EP1331001B1 (de) 2004-07-21
JP2004512355A (ja) 2004-04-22
ES2174734B1 (es) 2003-10-01

Similar Documents

Publication Publication Date Title
DK455286A (da) Farmaceutisk middel med langsom frigoering og fremgangsmaade til dets fremstilling
IS4146A (is) Lyfjablanda til að gefa dýrum um munn sem inniheldur prótonupumpublokkara
CA2396159A1 (en) Novel substituted benzimidazole dosage forms and method of using same
TR200500745T2 (tr) Damar gelişimi inhibitörleri olarak kuinazolin türevleri.
GEP20053510B (en) Substituted Pyrrolopyridinone Derivatives Useful as Phosphodiesterase Inhibitors
HUP0103494A2 (en) Process for intermittent administration use of growth hormone secretagogues for the manufacture of pharmaceutical compositions for intermittent administration and kit comprising thereof
SI1341524T1 (sl) Farmacevtski pripravek v obliki paste, ki obsega kislinsko labilno učinkovino
HUP0000141A2 (hu) Eljárás legfeljebb 90 tömeg% gyógyhatású anyagot tartalmazó pelletek előállítására
DE60104442D1 (de) Neue galenische dispergierbare und lösliche paracetamol-zubereitung, methode zu deren herstellung und deren anwendungen
YU81503A (sh) Postupak za proizvodnju farmaceutskog preparata sa niskom dozom, koji ima uniformnu raspodelu i snagu leka
ATE329608T1 (de) Formulierungen von copolymer 1 (glatirameracetat) zur oralen, nasalen und pulmonalen verabreichung
IL150528A0 (en) Ibuprofen containing active agent preparation
CA2380757A1 (en) Pharmaceutical agent comprising a benzamide derivative as active ingredient
MXPA05008403A (es) Uso de acido comestible en formas de dosis solidas farmaceuticas de rapida dispersion.
DE60103276D1 (de) Eine stabile pharmazeutische formulierung die torsemid modifikation ii enthält
DOP2001000130A (es) Sistema de administración oral controlada para la ingestión diaria de ciprofloxacina
HRP20050342B1 (hr) Farmaceutska formulacija olanzapina
ATE408619T1 (de) Lh-rh-antagonisten, deren herstellung und verwendung als arzneimittel
SE0001916D0 (sv) Novel formulation
NO20054417L (no) Fremgangsmate for fremstilling av farmasoytiske preperater i form av fibratholdige tabletter og de derved fremstilte tabletter
ATE264125T1 (de) Pharmazeutische zusammensetzung enthaltend trichloroessigsäure, 2-oh benzoesäure und menthol zur topischen anwendung und verfahren zu deren herstellung
DE60121142D1 (de) Zusammensetzung die paracetamol und niflumic säure enthält
NZ532449A (en) Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for use in treatment of ulcerative colitis and Crohn's disease
UA28457A (uk) Лікарський засіб "діпрацетам", що має знеболювальну та жарознижувальну дію та спосіб його одержання
UA32115A (uk) Спосіб одержання таблеток кислотовміщуючого засобу "амінокапронова кислота"

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties